Insight into Classification and Risk Stratification of Head and Neck Squamous Cell Carcinoma in Era of Emerging Biomarkers with Focus on Histopathologic Parameters

Mäkitie AA, Agaimy A, Almangush A (2022)

Publication Type: Journal article

Publication year: 2022

Journal

Cancers MDPI

Book Volume: 14

Article Number: 5514

Journal Issue: 22

DOI: 10.3390/cancers14225514

Abstract

Tumor-node-metastasis (TNM) staging system is the cornerstone for treatment planning of head and neck squamous cell carcinoma (HNSCC). Many prognostic biomarkers have been introduced as modifiers to further improve the TNM classification of HNSCC. Here, we provide an overview on the use of the recent prognostic biomarkers, with a focus on histopathologic parameters, in improving the risk stratification of HNSCC and their application in the next generation of HNSCC staging systems.

Authors with CRIS profile

Abbas Agaimy Medizinische Fakultät

Involved external institutions

Helsingin yliopisto / University of Helsinki FI Finland (FI) University of Turku / Turun yliopisto FI Finland (FI)

How to cite

APA:

Mäkitie, A.A., Agaimy, A., & Almangush, A. (2022). Insight into Classification and Risk Stratification of Head and Neck Squamous Cell Carcinoma in Era of Emerging Biomarkers with Focus on Histopathologic Parameters. Cancers, 14(22). https://doi.org/10.3390/cancers14225514

MLA:

Mäkitie, Antti A., Abbas Agaimy, and Alhadi Almangush. "Insight into Classification and Risk Stratification of Head and Neck Squamous Cell Carcinoma in Era of Emerging Biomarkers with Focus on Histopathologic Parameters." Cancers 14.22 (2022).

BibTeX: Download